Research Grants show all

NIH1

Publications show all

Talon Therapeutics has published 4 articles.

Patents show all

25Applications18Issued

Clinical Trials show all

1Phase 11Phase 1/Phase 21Phase 2

SEC Filings show all

8-K10910-Q2210-K8D5S-11

SEC Form D Funding Events

DateOfferedSoldType
2012-01-13$70,390,800$10,315,800Equity, Option to Acquire, Security to be Acquired
2012-01-13$2,291,000$258,000Equity
2010-06-18$97,562,000$37,512,000Equity, Option to Acquire
2009-10-22$16,267,844$16,267,844Equity, Option to Acquire
2005-11-08UnknownUnknownOther (Paper Filing)

Key Executives

  • Steven R. Deitcher, M.D.
    Executive Officer, Director
  • Anne E. Hagey
    Executive Officer
  • John P. Iparraguirre
    Executive Officer
  • Arie S. Belldegrun, M.D.
    Director
  • Paul V. Maier
    Director
  • Leon E. Rosenberg, M.D.
    Director
  • Michael Weiser, M.D.
    Director
  • Linda E. Wiesinger
    Director
  • Anne E. Hagey, M.D.
    Executive Officer
  • Tyler M. Nielsen
    Executive Officer
  • Craig W. Carlson
    Executive Officer
  • Howard P. Furst, M.D.
    Director
  • Jonathan Leff
    Director
  • Nishan de Silva
    Director
  • Andrew Ferrer
    Director
  • Robert J. Spiegel
    Director
  • Samir M. Gharib
    Executive Officer
  • Cecilia Gonzalo
    Director